ARCH:TSXV, Arch Biopartners Inc.

ARCH stock overview

Arch Biopartners Inc. (ARCH:TSXV) closed at $0.830 on October 22, 2026, down 5.68% on the day. The stock trades 42.8% below its 52-week high of $1.45 and 112.8% above its 52-week low of $0.390. Over the past year, it lost 4.3%. Arch Biopartners Inc. is part of the Life Sciences sector (Pharmaceuticals).

Key figures

Price

$0.830

Day change

-5.68%

Volume

8,379

Average volume

56,725

Market cap

56M+

52-week range

$0.390 – $1.45

50-day average

$0.945

200-day average

$0.800

Price action over the past year

In 252 trading sessions since October 21, 2025, ARCH closed higher on 98 days (39%). Its best day was June 22, 2026 (+25.37%) and its worst was February 4, 2026 (-20.87%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 7 times.

Recent signals

• Oct 21, 2026: Trading sideways between $0.790 and $0.900 over 30 days (Sideways scanner)

ARCH news

• Aug 31, 2026: Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide
• Aug 11, 2026: Arch Biopartners to Expand Ongoing Phase 2 LSAT Peptide Trial to The US
• Aug 11, 2026: Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States

About Arch Biopartners Inc.

Arch Biopartners Inc is a biotechnology company. The Companis engaged in development of technologies that have the potential to make a medical or commercial impact. Its portfolio includes AB569, MetaMx, MetaBlok, Borg, and Arch Inflammation.

Similar stocks

• EBM:TSXV
• GSD:TSXV
• RX:TSXV
• CPH:TSX
• VPI:TSXV
• VXL:TSXV
• TLT:TSXV
• MPH:TSXV

Find more stocks like ARCH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.